logo-loader
viewTHC Global Group Ltd

THC Global Group completes name change from The Hydroponics Company Ltd

The new name reflects strategic developments in the company’s global medicinal cannabis business.

Hand holding marijuana leaf
THC Global’s supply capacity is among the world’s largest cannabis producers

THC Global Group Limited (ASX:THC) has completed a change of name from The Hydroponics Company Ltd with the ticker remaining as THC.

The change was approved by shareholders at the company’s extraordinary general meeting on November 15, 2018.

This name was proposed as it was considered to better reflect the strategic developments in the business and the importance of advancing established global operations and international partnerships.

READ: THC Global Group makes move to acquire near-term Canadian cannabis producer

Directors also believed it recognised the significant value THC Global was now creating and into the future, across both medicinal and recreational cannabis markets.

Chief executive officer Ken Charteris said: “THC Global is preparing to enter new international markets and secure a stronghold as a full-scale global cannabis producer.

“The name change reflects our established operations, partnerships and alliances and our global expansion plans.

“We are particularly excited by the potential to increase our revenue generation in Canada in the coming months.”

‘Farm to Pharma’ model

THC Global operates under a ‘Farm to Pharma’ pharmaceutical model and is delivering medicinal cannabis products to Australian patients through existing access schemes.

Having secured significant growing capacity over two sites and an industry-leading pharmaceuticals biomanufacturing facility with testing and product development laboratory, THC Global is in prime position to service domestic and international patients.

READ: The Hydroponics Company supplies first Australian patients prescribed cannabidiol products

The company’s commercial partners operate across four continents, supporting future international growth.

THC Global believes the new name captures the growth objectives and direction for the company as a leading medicinal cannabis business with tier one growing and manufacturing capacity in Australia and ability to supply and expand internationally.

READ: The Hydroponics Company well placed to grow as Canada set to legalise recreational cannabis

In addition to its core medicinal cannabis business, THC Global owns two Canadian companies, Crystal Mountain Products and Vertical Canna Inc.

Vancouver-based Crystal Mountain operates a revenue-generating global hydroponics retailer and distributor of equipment, material, and nutrients to cannabis growers and producers.

Vertical Canna is an investment vehicle through which THC Global intends to build, through acquisitions and strategic partnerships, a vertically integrated Canadian cannabis producer and retailer.

The company said it would continue to expand its Crystal Mountain division and continue to accelerate the build-out of its medicinal cannabis growing and manufacturing facilities under its ‘Farm to Pharma’ model.

Quick facts: THC Global Group Ltd

Price: 0.375 AUD

ASX:THC
Market: ASX
Market Cap: $51.48 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

THC Global granted manufacturing licence by Australian Office of Drug Control

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive Investors on the manufacturing licence granted to the cannabis company by the Australian Office of Drug Control.   "It's a significnat milestone ... we now are a farm-to-pharma process which...

on 13/6/19

3 min read